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Abstracts for the Sixth Biennial SIRS Conference
S344  Poster Session III
the full sample. The MEMS group reported strong satisfaction with the 
text-messages. Recruitment has been completed, and analyses from the full 
sample will be ready to present at the meeting.
Discussion: Initial results indicate that MEMS is acceptable and may suc-
cessfully improve motivation in people with schizophrenia-spectrum disor-
ders. However, additional analyses with the full sample are needed to more 
rigorously test the feasibility and effectiveness of MEMS.
S51. MOTIVATIONAL ENHANCEMENT 
IMPROVES TREATMENT OUTCOMES OF 
MOBILE-BASED COGNITIVE REMEDIATION IN 
INDIVIDUALS WITH SCHIZOPHRENIA
Eun Jin Kim*,1, YongChun Bahk1, Kee-Hong Choi1
1Korea University
Background: Cognitive impairment is a core feature of schizophrenia, which limits 
functions of individuals with schizophrenia and negatively influences their qual-
ity of life (Green, 1993; Green et al, 2000; Heaton et al., 2001; Heinrichs, 1998). 
While pharmacological treatment is known to have a limited effect on impaired 
cognition in schizophrenia (Marder, 2006; Rund and Borg, 1999; Elie et  al., 
2010), a majority of literature has concluded that cognitive remediation(CR) 
produces small to moderate improvements (McGurk et al., 2007; Wykes et al., 
2011). As the smartphone user population continues to increase, the effective-
ness of CR based on mobile devices have started to be studied. While CR is 
effective in improving cognitive deficit, treatment adherence and engagement of 
participants in the real world setting is known to be poor compared to laboratory 
setting. Thus, in the current randomized controlled study, we aimed to investigate 
whether motivational intervention would enhance motivation, treatment adher-
ence and neurocognitive function of individuals with schizophrenia.
Methods: All subjects participated in a group-based CR using mobile appli-
cation (mCR) twice a week for five weeks, and were given opportunity to 
practice voluntarily outside the treatment sessions. While CR only group 
participated in usual CR with Q&A sessions, experimental group partici-
pated CR sessions integrated with motivational intervention. For motiva-
tional enhancement (ME), we employed principles (e.g., goal setting, linking 
of CR with life goals, etc) of the bridging group (Medalia, Revheim, & 
Herlands, 2009) along with key aspects of motivational interviewing (e.g., 
open end questions, affirmation, reflect, and summary). We hypothesized 
that compared to CR only group, CR+ME group would show higher levels 
of intrinsic motivation, attendance rate and extra voluntary training hours, 
and greater improvement in cognitive functions.
Results: We are undergoing the current project, and a total of 14 partici-
pants were randomly assigned to either CR+ME (n=8) or CR only (n=5). 
Among 14 participants, two participants dropped out (n=1 experimental 
group and n=1 control group).
Independent sample t-test were used to compare scores of demographics 
and clinical characteristics between groups, and no differences were found 
except for the PANSS excitement subscale (t = 2.91, P < .05) at the time of 
pre-treatment. Due to a small sample, we conducted paired sample t-tests 
to examine whether there was a significant difference between the pre and 
post-test for two groups, respectively. The paired t-test revealed improve-
ments in coding, TMT-B, logical memory I and K-AVLT immediate recall 
performances of CR+ME (t=-2.92, p < .01; t=-3.65, p < .05; t=-3.20, 
p < .05; t=-2.89, p < .05), but not CR only. In addition, there were pre 
and post-treatment differences in motivation variables (MSQ) for CR+ME. 
Comparing task related motivational level of first session to the final 10th 
session, CR+ME showed increased identified regulation(IR) score of MSQ 
and decreased external regulation(ER) score (IR=22.3(3.2), 23.5(3.7); 
ER= 10.67 (3.88), 6.67 (3.08)).
Discussion: We conclude that ME is promising to further enhance neuro-
cognitive and motivational outcomes of mCR. The data collection process 
is expected to be completed in late January 2018, and the results will be 
accordingly updated by the time of presentation at SIRS 2018. Limitations 
and future directions will be discussed.
S52. WORKING MECHANISMS OF VIRTUAL 
REALITY BASED CBT FOR PARANOIA: 
A RANDOMIZED CONTROLLED TRIAL 
EXAMINING COGNITIVE BIASES, SCHEMATIC 
BELIEFS AND SAFETY BEHAVIOR
Chris Geraets*,1, Marije Van Beilen1, Roos Pot-Kolder2, 
Mark Van der Gaag2, Wim Veling1
1University Medical Center Groningen; 2VU Amsterdam
Background: Recently, the efficacy of a novel virtual reality based cogni-
tive behavior therapy (VR-CBT) for paranoia was demonstrated. Cognitive 
biases, cognitive limitations, negative schematic beliefs and safety behavior 
have been associated with paranoid ideations and delusions. It is unknown 
whether VR-CBT affects these associated factors, and how changes in these 
factors relate to changes in paranoid ideation.
Methods: In this multi-center randomized controlled trial patients with a 
psychotic disorder and paranoia were randomized to VR-CBT (n = 58) or 
treatment as usual (TAU; n = 58). VR-CBT consisted of maximally sixteen 
60-minute individual therapy sessions. Paranoia, safety behavior, schematic 
beliefs, cognitive biases and limitations were assessed at baseline, post-treat-
ment (at three months) and follow-up (at six months). Mixed model analyses 
were conducted to study treatment effects. Mediation analyses were performed 
to explore putative working mechanisms by which VR-CBT reduced paranoia.
Results: VR-CBT, but not TAU, led to reductions in jumping to conclu-
sions, attention for threat bias and social cognition problems. Schematic 
beliefs remained unaffected. The effect of VR-CBT on paranoia was medi-
ated by reductions in safety behavior and social cognition problems.
Discussion: VR-CBT affects multiple mechanisms that are associated with 
paranoid ideation. Although maintaining factors of paranoia are likely to 
influence each other, targeting safety behavior and social cognitive prob-
lems seems effective in breaking the vicious circle of paranoia.
S53. COMPARISON OF RALOXIFENE AND 
ISRADIPINE AS AN ADJUNCTIVE TREATMENT 
IN COGNITIVE DEFICITS OF PATIENTS WITH 
SCHIZOPHRENIA
Bita Vahdani*,1, Alireza Armani kian1, Abdolreza Esmaeilzadeh1, 
Saeedeh Zenoozian1, Vida Yousefi1, Saeedeh Mazloomzadeh1
1Zanjan University of Medical Sciences
Background: Cognitive impairment is the most important feature of schizo-
phrenia that leads to severe social and functional disability. Improving neu-
rocognitive physiopathologic aspect of schizophrenia is a current challenge 
to identify the pathway to develop goal directed clinical interventions in prac-
tice. In the current study we investigated the effect of raloxifine as a selective 
estrogen modulator and isradipine as a voltage gated L type calcium channel 
blocker on the enhancement of schizophrenic patients’ cognitive deficits.
Methods: We designed a double blind randomized, parallel, placebo con-
trolled clinical trials. 60 patients with schizophrenia randomized in 3 spe-
cific groups. The first group received isradipine 5 mg, the second raloxifine 
60 mg and the third placebo for 6 consequent weeks, in the same shape cap-
sules, 2 times a day, alongside treatment with the conventional antipsychot-
ics. The initial and final lab tests, ECG, as well as cognitive tests in specific 
domains such as attention, processing speed, executive function and verbal 
memory were carried out.
Results: Our findings, revealed a remarkable association between adjunctive 
treatment of raloxifine in verbal memory deficits. moreover, isradipine treat-
ment indicated significant improvement relative to placebo in verbal memory as 
well as attention dysfunction in some variables of the Stroop test. However, no 
effect was observed in processing speed and executive function deficits.
Discussion: The study provides the first evidence to our knowledge, which 
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